Entering text into the input field will update the search result below

FDA approves Lannett's Diazepam Oral Solution, 5 mg/5 ml

  • Lannett Company (NYSE:LCI) announces that FDA has approved its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution, 5 mg/5 mL, the therapeutic equivalent to the reference drug, Roxane Laboratories' Diazepam Oral Solution, 5 mg/5 mL.
  • According to IMS, the U.S. wholesale market is ~$4M.
  • The company says its Diazepam Oral Solution product will be second on the market. Market launch will commence in fiscal Q1 (calendar Q3).

Recommended For You

Related Stocks

SymbolLast Price% Chg
LCINQ--
Lannett Company, Inc.